+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

HLA Typing for Transplant Market Research Report by Technology, Product & Service, Application, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • PDF Icon

    Report

  • 131 Pages
  • January 2023
  • Region: United States
  • 360iResearch™
  • ID: 5722098
The United States HLA Typing for Transplant Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States HLA Typing for Transplant Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States HLA Typing for Transplant Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States HLA Typing for Transplant Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States HLA Typing for Transplant Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States HLA Typing for Transplant Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States HLA Typing for Transplant Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the market is studied across Molecular Assay Technologies and Non-Molecular Assay Technologies. The Molecular Assay Technologies is is further studied across PCR-Based Molecular Assays and Sequencing-Based Molecular Assays. The PCR-Based Molecular Assays is is further studied across Real-Time PCR, Sequence-Specific Oligonucleotide-PCR, and Sequence-Specific Primer-PCR. The Sequence-Specific Oligonucleotide-PCR is is further studied across Next-Generation Sequencing and Sanger Sequencing.
  • Based on Product & Service, the market is studied across Instruments, Reagents & Consumables, and Software & Services.
  • Based on Application, the market is studied across Diagnostic Applications and Research Applications. The Diagnostic Applications is is further studied across Antibody Screening and Chimerism Monitoring.
  • Based on End-User, the market is studied across Hospitals & Transplant Centers, Independent Reference Laboratories, and Research Laboratories & Academic Institutes.
  • Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States HLA Typing for Transplant Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States HLA Typing for Transplant Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States HLA Typing for Transplant Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States HLA Typing for Transplant Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States HLA Typing for Transplant Market, including Affymetrix, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., CareDx, Inc., F. Hoffman-La Roche Ltd., Fujirebio, Inc., Genome Diagnostics B.V., Hologic, Inc., Illumina, Inc., Immucor, Inc., Luminex Corporation, Omixon Inc., QIAGEN N.V., Takara Bio Inc., TBG Diagnostics Ltd., and Thermo Fisher Scientific, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States HLA Typing for Transplant Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States HLA Typing for Transplant Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States HLA Typing for Transplant Market?
4. What is the competitive strategic window for opportunities in the United States HLA Typing for Transplant Market?
5. What are the technology trends and regulatory frameworks in the United States HLA Typing for Transplant Market?
6. What is the market share of the leading vendors in the United States HLA Typing for Transplant Market?
7. What modes and strategic moves are considered suitable for entering the United States HLA Typing for Transplant Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing private and public investment to improve the healthcare sector in the U.S.
5.1.1.2. Rapidly increasing number of transplantation procedures
5.1.2. Restraints
5.1.2.1. Requirement of sophisticated equipment and trained personnel increasing the cost of HLA typing
5.1.3. Opportunities
5.1.3.1. Ongoing research to enhance the accuracy and speed of HLA testing
5.1.3.2. Innovation of new technologies to address nonspecific antibody reactivity in samples
5.1.4. Challenges
5.1.4.1. Complexity associated with HLA typing due to occurrence of high number of markers
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. HLA Typing for Transplant Market, by Technology
6.1. Introduction
6.2. Molecular Assay Technologies
6.3.1. PCR-Based Molecular Assays
6.3.2.1. Real-Time PCR
6.3.2.2. Sequence-Specific Oligonucleotide-PCR
6.3.2.3.1. Next-Generation Sequencing
6.3.2.3.2. Sanger Sequencing
6.3.2.3. Sequence-Specific Primer-PCR
6.3.2. Sequencing-Based Molecular Assays
6.3. Non-Molecular Assay Technologies

7. HLA Typing for Transplant Market, by Product & Service
7.1. Introduction
7.2. Instruments
7.3. Reagents & Consumables
7.4. Software & Services

8. HLA Typing for Transplant Market, by Application
8.1. Introduction
8.2. Diagnostic Applications
8.3.1. Antibody Screening
8.3.2. Chimerism Monitoring
8.3. Research Applications

9. HLA Typing for Transplant Market, by End-User
9.1. Introduction
9.2. Hospitals & Transplant Centers
9.3. Independent Reference Laboratories
9.4. Research Laboratories & Academic Institutes

10. California HLA Typing for Transplant Market
10.1. Introduction

11. Florida HLA Typing for Transplant Market
11.1. Introduction

12. Illinois HLA Typing for Transplant Market
12.1. Introduction

13. New York HLA Typing for Transplant Market
13.1. Introduction

14. Ohio HLA Typing for Transplant Market
14.1. Introduction

15. Pennsylvania HLA Typing for Transplant Market
15.1. Introduction

16. Texas HLA Typing for Transplant Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis, By Key Player
17.3. Market Share Analysis, By Key Player
17.4. Product Portfolio Analysis, By Key Player
17.5. Competitive Scenario
17.5.1. Merger & Acquisition
17.5.2. Agreement, Collaboration, & Partnership
17.5.3. New Product Launch & Enhancement
17.5.4. Investment & Funding
17.5.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Affymetrix, Inc.
18.2. Becton, Dickinson, and Company
18.3. Bio-Rad Laboratories, Inc.
18.4. CareDx, Inc.
18.5. F. Hoffman-La Roche Ltd.
18.6. Fujirebio, Inc.
18.7. Genome Diagnostics B.V.
18.8. Hologic, Inc.
18.9. Illumina, Inc.
18.10. Immucor, Inc.
18.11. Luminex Corporation
18.12. Omixon Inc.
18.13. QIAGEN N.V.
18.14. Takara Bio Inc.
18.15. TBG Diagnostics Ltd.
18.16. Thermo Fisher Scientific, Inc.

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET DYNAMICS
FIGURE 8. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2030
FIGURE 12. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY MOLECULAR ASSAY TECHNOLOGIES, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY PCR-BASED MOLECULAR ASSAYS, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY SEQUENCE-SPECIFIC OLIGONUCLEOTIDE-PCR, 2018-2030 (USD MILLION)
FIGURE 16. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY SANGER SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY SEQUENCE-SPECIFIC PRIMER-PCR, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY SEQUENCING-BASED MOLECULAR ASSAYS, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY NON-MOLECULAR ASSAY TECHNOLOGIES, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2030 (%)
FIGURE 22. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT & SERVICE, 2030
FIGURE 24. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
FIGURE 25. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
FIGURE 26. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
FIGURE 27. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 28. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 29. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 30. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
FIGURE 31. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY ANTIBODY SCREENING, 2018-2030 (USD MILLION)
FIGURE 32. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY CHIMERISM MONITORING, 2018-2030 (USD MILLION)
FIGURE 33. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
FIGURE 34. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 35. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 36. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 37. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY HOSPITALS & TRANSPLANT CENTERS, 2018-2030 (USD MILLION)
FIGURE 38. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
FIGURE 39. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
FIGURE 40. CALIFORNIA HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 41. FLORIDA HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. ILLINOIS HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. NEW YORK HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. OHIO HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. PENNSYLVANIA HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. TEXAS HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 48. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 49. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY MOLECULAR ASSAY TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY MOLECULAR ASSAY TECHNOLOGIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY PCR-BASED MOLECULAR ASSAYS, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY PCR-BASED MOLECULAR ASSAYS, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY REAL-TIME PCR, BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY SEQUENCE-SPECIFIC OLIGONUCLEOTIDE-PCR, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY SEQUENCE-SPECIFIC OLIGONUCLEOTIDE-PCR, BY STATE, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY STATE, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY SANGER SEQUENCING, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY SANGER SEQUENCING, BY STATE, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY SEQUENCE-SPECIFIC PRIMER-PCR, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY SEQUENCE-SPECIFIC PRIMER-PCR, BY STATE, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY SEQUENCING-BASED MOLECULAR ASSAYS, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY SEQUENCING-BASED MOLECULAR ASSAYS, BY STATE, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY NON-MOLECULAR ASSAY TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY NON-MOLECULAR ASSAY TECHNOLOGIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY INSTRUMENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY REAGENTS & CONSUMABLES, BY STATE, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY SOFTWARE & SERVICES, BY STATE, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY ANTIBODY SCREENING, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY ANTIBODY SCREENING, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY CHIMERISM MONITORING, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY CHIMERISM MONITORING, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY RESEARCH APPLICATIONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY HOSPITALS & TRANSPLANT CENTERS, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY HOSPITALS & TRANSPLANT CENTERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. CALIFORNIA HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 48. CALIFORNIA HLA TYPING FOR TRANSPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. CALIFORNIA HLA TYPING FOR TRANSPLANT MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 50. CALIFORNIA HLA TYPING FOR TRANSPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. CALIFORNIA HLA TYPING FOR TRANSPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. FLORIDA HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 53. FLORIDA HLA TYPING FOR TRANSPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. FLORIDA HLA TYPING FOR TRANSPLANT MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 55. FLORIDA HLA TYPING FOR TRANSPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. FLORIDA HLA TYPING FOR TRANSPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. ILLINOIS HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 58. ILLINOIS HLA TYPING FOR TRANSPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. ILLINOIS HLA TYPING FOR TRANSPLANT MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 60. ILLINOIS HLA TYPING FOR TRANSPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. ILLINOIS HLA TYPING FOR TRANSPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. NEW YORK HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 63. NEW YORK HLA TYPING FOR TRANSPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. NEW YORK HLA TYPING FOR TRANSPLANT MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 65. NEW YORK HLA TYPING FOR TRANSPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. NEW YORK HLA TYPING FOR TRANSPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. OHIO HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 68. OHIO HLA TYPING FOR TRANSPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. OHIO HLA TYPING FOR TRANSPLANT MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 70. OHIO HLA TYPING FOR TRANSPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. OHIO HLA TYPING FOR TRANSPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. PENNSYLVANIA HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 73. PENNSYLVANIA HLA TYPING FOR TRANSPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. PENNSYLVANIA HLA TYPING FOR TRANSPLANT MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 75. PENNSYLVANIA HLA TYPING FOR TRANSPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. PENNSYLVANIA HLA TYPING FOR TRANSPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. TEXAS HLA TYPING FOR TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 78. TEXAS HLA TYPING FOR TRANSPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. TEXAS HLA TYPING FOR TRANSPLANT MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 80. TEXAS HLA TYPING FOR TRANSPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. TEXAS HLA TYPING FOR TRANSPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 83. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 84. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 85. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET RANKING, BY KEY PLAYER, 2022
TABLE 86. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 87. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 88. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET MERGER & ACQUISITION
TABLE 89. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 90. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 91. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET INVESTMENT & FUNDING
TABLE 92. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 93. UNITED STATES HLA TYPING FOR TRANSPLANT MARKET: LICENSE & PRICING

Companies Mentioned

  • Affymetrix, Inc.
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • F. Hoffman-La Roche Ltd.
  • Fujirebio, Inc.
  • Genome Diagnostics B.V.
  • Hologic, Inc.
  • Illumina, Inc.
  • Immucor, Inc.
  • Luminex Corporation
  • Omixon Inc.
  • QIAGEN N.V.
  • Takara Bio Inc.
  • TBG Diagnostics Ltd.
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...